Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial - White, H; Hirulog and Early Reperfusion or Occlusion (HERO)-2 Trial Investigators (Lancet, 2001)
(9296):